RxDoctor Payments Data

Javier Nazar

General Practice · Redmond, WANPI 1578359147

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,782 of the $6,607 with a category attached, or 87.5%. Eli Lilly accounts for 80.7% of it on its own, with 2 other manufacturers making up the rest. Among general practice clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,607in general payments, 2019–2025

Across 58 payments — averaging $113.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$5K
  • Novartis$1K
  • Abbott$23
$2,043,272in research payments, 2019–2025

Across 2 payments — averaging $1,021,636 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M

What the payments were for

  • Travel & lodging$5,78288%
  • Food & beverage$79012%
  • Education$361%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly51$5,334
Novartis6$1,250
Abbott1$23

How this compares

$6,607 in reported general payments places this provider in the 95th percentile of 2,229 general practice providers in Washington.

See all general practice providers in Washington →

Other general practice in Redmond

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →